Cost determinants of tuberculosis management in a low-prevalence country

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 2, 2006, Pages 146-152

  Bocchino, M ^a   Greco, S ^a   Rosati, Y ^a   Mattioli, G ^a   Marruchella, A ^a   De Mori, P ^b   Bibbolino, C ^b   Girardi, E ^b   Squarcione, S ^b   Saltini, Cesare ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Case outcome; Costs; Hospital care; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; DEMOGRAPHY; DRUG COST; DRUG TOLERANCE; FEMALE; FEVER; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TUBERCULOSIS;

ADULT; AGED; ANTITUBERCULAR AGENTS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; ITALY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; RETROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 33244486101     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Nunn P, Harries A, Godfrey-Faussett P, Gupta R, Maher D, Raviglione M. The research agenda for improving health policy, systems performance, and service delivery for tuberculosis control: a WHO perspective. Bull World Health Organ 2002; 80: 471-476.
2. Floyd K, Wilkinson D, Gilks C. Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. BMJ 1997; 3: 1407-1411.
3. Vassall A, Bagdadi S, Bashour H, Zaher H, Maaren P V. Cost-effectiveness of different treatment strategies for tuberculosis in Egypt and Syria. Int J Tuberc Lung Dis 2002; 6: 1083-1090.
4. Moalosi G, Floyd K, Phatshwane J, Moeti T, Binkin N, Kenyon T. Cost-effectiveness of home-based care versus hospital care for chronically ill tuberculosis patients, Francistown, Botswana. Int J Tuberc Lung Dis 2003; 7 (Suppl 1): S80-S85.
5. Floyd K, Skeva J, Nyirenda T, Gausi F, Salaniponi F. Cost and cost-effectiveness of increased community and primary care facility in tuberculosis care in Lilongwe, Malawi. Int J Tuberc Lung Dis 2003; 7 (Suppl 1): S29-S37.
6. Broekmans J F, Migliori G B, Rieder H L, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Eur Respir J 2002; 19: 765-775.
7. Gunnels J J, Bates J H, Swindoll H. Infectivity of sputum positive tuberculosis patients on chemotherapy. Am Rev Respir Dis 1974; 109: 323-330.
8. Brooks S M, Lassiter N L, Young E C. A pilot study concerning the infection risk of sputum positive tuberculosis patients on chemotherapy. Am Rev Respir Dis 1973; 108: 799-804.
9. Abeles H. Early hospital discharge of tuberculosis patients with sputum containing acid-fast bacilli on microscopic examination. Am Rev Respir Dis 1973; 108: 975-977.
10. Centers for Diseases Control and Prevention: guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. MMWR 1994; 43: RR-13.
11. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: code of practice. Thorax 2000; 55: 887-901.
12. Ministre della Sanita'. Documento di lineeguida per il controllo della malattia tubercolare, su proposta del Ministro della sanita', ai sensi dell'art. 115, comma 1, lettera b, del decreto legislativo 31 marzo 1998, n. 112. Gazzetta Ufficiale della Repubblica Italiana del 18 febbraio 1999, n. 40 (suppl 35). www.ministerosalute.it
13. Brown R E, Miller B, Taylor W R, et al. Health care expenditure for tuberculosis in the United States. Arch Intern Med 1995;155: 1595-1600.
14. Shulkin D J, Brennan P J. The cost of caring for patients with tuberculosis: planning for a disease on the rise. Am J Infect Control 1995; 23: 1-4.
15. Rosenblum L S, Castro K G, Dooley S, Morgan M. Effect of HIV infection and tuberculosis on hospitalization and cost of care for young adults in the United States, 1985 to 1990. Ann Inter Med 1994; 121: 786-792.
16. Lauria F N, Carmosino F, Piselli P, et al. Il controllo di gestione: analisi dei costi sostenuti dall'IRCCS 'L. Spallanzani' in relazione alle prestazioni assistenziali erogate nell'anno 1999. Giornale Italiano dell'AIDS 2000; 11: 129-144.
17. Deruaz J, Zellweger J P. Directly observed therapy for tuberculosis in a low prevalence region: first experience at the Tuberculosis Dispensary in Lausanne. Swiss Med Wkly 2004; 134: 552-558.
18. EuroTB. Surveillance of Tuberculosis in Europe. Country profile. Annual report 2002. St Maurice, France: Institut de Veille Sanitaire EuroTB, 2002. www.eurotb.org
19. MacIntyre C R, Plant A J, Hendrie D. Shifting the balance between in-patient and out-patient care for tuberculosis results in economics savings. Int J Tuberc Lung Dis 2001; 5: 266-271.
20. Gruppo di Lavoro Tubercolosi National Institute for Infectious Diseases L Spallanzani. Protoocollo di gestione clinica della tubercolosi. Rome, Italy: INMI, 2003. www.inmi.it
21. Fennelly K P, Martyny J W, Fulton K E, Orme I M, Cave D M, Heifets E B. Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness. Am J Respir Crit Care Med 2004; 169: 553-554.
22. Hellyer T J, DesJardin E E, Hehman G E, Cave M D, Eisenach K D. Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis. J Clin Microbiol 1999; 37: 290-295.
23. Hellyer T J, Desjardin E E, Teixeira E, Perkins M D, Cave M D, Eisenach K D. Detection of viable Mycobacterium tuberculosis by reverse transcriptase-strand displacement amplificartion of mRNA. J Clin Microbiol 1999; 37: 518-523.
24. Desjardin E E, Perkins M D, Wolski K, et al. Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy. Am J Respir Crit Care Med 1999; 160: 203-210.
25. Ormerod E P, Horsfield N, Green R M. Tuberculosis treatment outcome monitoring: Blackburn 1988-2000. Int J Tuberc Lung Dis 2002; 6: 662-665.
26. Migliori G B, Ambrosetti M, Besozzi G, et al. Cost-comparison of different management policies for tuberculosis patients in Italy. Bull World Health Organ 1999; 77: 467-476.
27. Cayla J A, Caminero J A, Rey R, et al. Current status of treatment completion and fatality among tuberculosis patients in Spain. Int J Tuberc Lung Dis 2004; 8: 458-464.